© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 17, 2020
The rate of adverse events was higher in patients suffering from both deep vein thrombosis and pulmonary embolisms than it was in just patients with DVT.
July 31, 2020
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
July 30, 2020
A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.
July 24, 2020
New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.
July 22, 2020
An expert explains why little progress has been made in disease prevalence and burden in the US.
July 13, 2020
Sixteen organizations are seeking to drive the practice forward after the 2008 Call to Action from the Surgeon General fell short in addressing the public health need regarding VTE.
June 12, 2020
Lower treatment odds for women were also observed in a set of 7 studies that had data on the subgroup of patients eligible for IV rtPA treatment.
June 09, 2020
Analysis of the Framingham Heart Study indicates the rate of ICH in older patients has been on the rise and suggests anticoagulant use could have contributed to this increase.
May 14, 2020
New research has found use of medication alone was noninferior to using medication and graduated compression socks for preventing VTE following non-emergency surgery.
May 06, 2020
New data from Mount Sinai Hospital suggests anticoagulant use could improve survival rates among patients hospitalized with COVID-19.